Literature DB >> 25739181

CA 19-9 in the presence of obstructive jaundice due to Mirizzi syndrome.

Udit Gibor, Zvi H Perry, Uri Netz, Yair Glazer, Lia Laufer, Boris Kirshtein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25739181

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  5 in total

Review 1.  Updates in Mirizzi syndrome.

Authors:  Alan Isaac Valderrama-Treviño; Juan José Granados-Romero; Mariana Espejel-Deloiza; Jonathan Chernitzky-Camaño; Baltazar Barrera Mera; Aranza Guadalupe Estrada-Mata; Jesús Carlos Ceballos-Villalva; Jonathan Acuña Campos; Rubén Argüero-Sánchez
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

2.  The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of Pancreas.

Authors:  Jayabal Pandiaraja; Subramanian Viswanathan; Thomas Babu Antomy; Sathyamoorthy Thirumuruganand; Dhandapani Subramanian Kumaresan
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Elevation of CA 19-9 in Mirizzi Syndrome in the Absence of Malignancy: A Case Report.

Authors:  Leena H Moshref; Rasha Abdulaziz Mandili; Murouj Almaghrabi; Rahaf Abdulrashid Abdulwahab; Rawan A Alosaimy; Jameel Miro
Journal:  Am J Case Rep       Date:  2021-07-01

4.  Mirrizi Syndrome and Markedly Elevated Levels of Carbohydrate Antigen 19-9 in the Absence of Malignant Disease.

Authors:  Natasha Shah; Eula Tetangco; Hafiz Muhammad Sharjeel Arshad; Hareth Raddawi
Journal:  Case Rep Gastrointest Med       Date:  2017-04-26

5.  Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant.

Authors:  Wei Liu; Qiaofei Liu; Wenqin Wang; Penghui Wang; Jieming Chen; Tao Hong; Ning Zhang; Binglu Li; Qiang Qu; Xiaodong He
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.